Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

As ED Visits Declined Amid COVID-19 in England, CV Deaths Ticked Up

News Daily News

As ED Visits Declined Amid COVID-19 in England, CV Deaths Ticked Up

December 23, 2020

MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI

News Conference News TCT 2020

MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI

Michael O'Riordan

October 17, 2020

Influenza and Acute CV Events Can Go Hand in Hand

News Daily News

Influenza and Acute CV Events Can Go Hand in Hand

August 25, 2020

Both CV Risk Factors, Complications Herald Higher COVID-19 Mortality

News Daily News

Both CV Risk Factors, Complications Herald Higher COVID-19 Mortality

August 19, 2020

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

News Features

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

July 20, 2020

Even Very Sick Kids Fare Well Despite Kawasaki-Like COVID-19 Symptoms

News Daily News

Even Very Sick Kids Fare Well Despite Kawasaki-Like COVID-19 Symptoms

May 21, 2020

Smartphones Aid in Remote Monitoring of Patients With Recent Acute MI

News Daily News

Smartphones Aid in Remote Monitoring of Patients With Recent Acute MI

April 21, 2020

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

News Daily News

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Michael O'Riordan

April 15, 2020

News Opinion Editor's Corner

COVID-19 and the Heart: Insights From the Front Lines

March 12, 2020

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

News Daily News

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

March 10, 2020

Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis

News Daily News

Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis

February 07, 2020

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.